trending Market Intelligence /marketintelligence/en/news-insights/trending/oOzqm8-0RN8GDwagOBiFaA2 content esgSubNav
In This List

Concert Pharmaceuticals director resigns

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Concert Pharmaceuticals director resigns

Concert Pharmaceuticals Inc. said Meghan FitzGerald resigned from the board, effective Dec. 11, due to other work commitments.

FitzGerald works in private equity and resigned her seat because one of her new portfolio companies invests in the biotechnology industry.

Lexington, Mass.-based Concert Pharmaceuticals operates as a clinical-stage biopharmaceutical company.